Proteomic analysis of chromium cytotoxicity in cultured rat lung epithelial cells

Chromium (Cr) has been widely used in industry for more than one century. Exposure to hexavalent Cr compounds is strongly associated with increasing risk of lung cancer. Extensive researches at DNA level indicated that generation of ROS from the reduction of Cr(VI) leading to DNA damage is the major cause of the toxicity and carcinogenicity of Cr(VI). The present study in cellular and protein levels confirmed that Cr(VI) induced apoptosis of lung epithelial cells (LEC) via ROS generation. To view the differentially expressed proteins in the process of Cr(VI) reduction, subcellular proteomics was applied and allowed the identification of more than 30 proteins with expression alteration. Most of those proteins are correlated with ROS‐elicited responses, which were further validated by Western blotting analysis, induction of p53 pathway and antioxidative treatment. The current findings provided additional evidence in protein level to support the claim that ROS generated during the process of Cr(VI) reduction are involved in the Cr(VI)‐induced toxicity and carcinogenesis.

[1]  J. Chiu,et al.  Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells , 2002, Journal of cellular biochemistry.

[2]  Xianglin Shi,et al.  Chromium(VI)-induced nuclear factor-кB activation in intact cells via free radical reactions , 1995 .

[3]  S. Patierno,et al.  Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. , 2002, DNA repair.

[4]  Xianglin Shi,et al.  Molecular mechanisms of Cr(VI)-induced carcinogenesis , 2002, Molecular and Cellular Biochemistry.

[5]  Y. Rojanasakul,et al.  Role of Reactive Oxygen Species and p53 in Chromium(VI)-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[6]  P. A. Lay,et al.  Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogen , 2002, JBIC Journal of Biological Inorganic Chemistry.

[7]  E. Peterson,et al.  Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. , 2003, Biochemistry.

[8]  R. Lauwerys,et al.  Carcinogenicity and mutagenicity of chromium. , 1980, Mutation research.

[9]  Y. Rojanasakul,et al.  Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: role of a Cr(IV)-mediated Fenton-like reaction. , 1994, Carcinogenesis.

[10]  S. Langård.  Chromium carcinogenicity; a review of experimental animal data. , 1988, The Science of the total environment.

[11]  D. E. Pritchard,et al.  Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). , 1998, Oncology reports.

[12]  J. Chiu,et al.  Induction of apoptosis by transforming growth factor‐β1 in the rat hepatoma cell line MCA‐RH7777: A possible association with tissue transglutaminase expression , 1993, Hepatology.

[13]  H. Bolt,et al.  The reduction of chromium (VI) to chromium (III) by glutathione: an intracellular redox pathway in the metabolism of the carcinogen chromate. , 1984, Toxicology.

[14]  T. Oyama,et al.  Oxidative Stress, hogg1 Expression and NF‐κB Activity in Cells Exposed to Low Level Chromium , 2003, Journal of occupational health.

[15]  Debasis Bagchi,et al.  Chromium (VI)‐induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene , 2001, Molecular and Cellular Biochemistry.

[16]  G. Bubley,et al.  CARCINOGENESIS: Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle , 1996 .

[17]  H. Fujita,et al.  Involvement of Ceramide in the Mechanism of Cr(VI)-induced Apoptosis of CHO Cells , 2004, Free radical research.

[18]  S. Flora,et al.  Threshold mechanisms and site specificity in chromium(VI) carcinogenesis , 2000 .

[19]  S. Patierno,et al.  Generation of S phase-dependent DNA double-strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of gamma-H2AX. , 2004, Carcinogenesis.

[20]  S. De Flora,et al.  Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved? , 1992, Carcinogenesis.

[21]  V. Castranova,et al.  Reduction of chromium(VI) and its relationship to carcinogenesis. , 1999, Journal of toxicology and environmental health. Part B, Critical reviews.

[22]  A. Standeven,et al.  Ascorbate is the principal reductant of chromium (VI) in rat liver and kidney ultrafiltrates. , 1991, Carcinogenesis.

[23]  Xianglin Shi,et al.  Participation of MAP kinase p38 and IκB kinase in chromium (VI)-induced NF-κB and AP-1 activation , 2000 .

[24]  P. A. Lay,et al.  Permeability, cytotoxicity, and genotoxicity of Cr(III) complexes and some Cr(V) analogues in V79 Chinese hamster lung cells. , 2000, Chemical research in toxicology.

[25]  P. Giangrande,et al.  Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. , 1995, Biochemistry.

[26]  G. Abbritti,et al.  Chromium VI-Induced Apoptosis in a Human Bronchial Epithelial Cell Line (BEAS-2B) and a Lymphoblastic Leukemia Cell Line (MOLT-4) , 2006, Journal of occupational and environmental medicine.

[27]  R. Paules,et al.  Cell cycle control, checkpoint mechanisms, and genotoxic stress. , 1999, Environmental health perspectives.

[28]  D. E. Pritchard,et al.  Apoptosis and P53 induction in human lung fibroblasts exposed to chromium (VI): effect of ascorbate and tocopherol. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  Jia-Ling Yang,et al.  Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. , 2000, Carcinogenesis.

[30]  N. D’Amelio,et al.  Metabolic pathways of carcinogenic chromium. , 2002, Environmental health perspectives.

[31]  Bing-Hua Jiang,et al.  p38 Signaling-mediated Hypoxia-inducible Factor 1α and Vascular Endothelial Growth Factor Induction by Cr(VI) in DU145 Human Prostate Carcinoma Cells* , 2002, The Journal of Biological Chemistry.

[32]  Kent D. Sugden,et al.  Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes. , 1992, Biochemistry.

[33]  Sverre Langrrd,et al.  One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. , 1990 .

[34]  Y. Rojanasakul,et al.  Protective Roles of NF-κB for Chromium(VI)-induced Cytotoxicity Is Revealed by Expression of IκB Kinase-β Mutant* , 2002, The Journal of Biological Chemistry.

[35]  P. A. Lay.  Chromium in Biology: Toxicology and Nutritional Aspects , 2003 .

[36]  K. Wetterhahn,et al.  Chromium toxicity and carcinogenesis. , 1990, International review of experimental pathology.

[37]  S. Patierno,et al.  Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. , 2003, Mutation research.

[38]  N. Knuckey,et al.  Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury , 2007, Neurobiology of Disease.